Abiopharma

🔍 Hamic William Thomas (Executive)

Company: INTERNATIONAL PAPER CO /NEW/ (IP)

Report Date: 2026-08-07

Detailed Transactions and Holdings:

• Sold 24,500 shares of Common Stock at $41.1999 per share (Direct)
  Date: 2026-08-07 | Code: S | equity_swap_involved: 0 | shares_owned_after: 106,952.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-08-07 | Code: H | nature_of_ownership: By Plan | shares_owned_after: 1,138.00 | Footnotes: F2
• Acquired 24,291 shares of Common Stock Units (Derivative)
  Date: 2026-08-07 | Code: I | equity_swap_involved: 0 | shares_owned_after: 39,570.00 | transaction_form_type: 4 | Footnotes: F4, F4, F4, F2, F2

Footnotes:

• F1: Represents the weighted average price for 24,500 shares purchased on August 7, 2026, at prices ranging from $41.0400 and $41.1999, inclusive. The reporting person undertakes to provide to International Paper Company, any security holder of International Paper Company, or the staff of the U.S. Securities and Exchange Commission, upon request, full information regarding the number of shares sold as reported in this Form 4.
• F2: Share numbers rounded.
• F3: Represents shares of International Paper common stock held through the International Paper Salaried Savings Plan. The information in this report is based on a plan statement as of August 6, 2026.
• F4: Represents an intra-plan transfer under the non-funded International Paper Company Deferred Compensation Savings Plan from another investment fund into the Company Stock Fund. The transaction does not involve an open-market purchase or sale of International Paper common stock. Each unit represents one share of International Paper common stock. The number of units will vary as the price of the issuer's common stock varies. The units will be settled in cash upon termination of employment. This information is based on a plan statement as of August 7, 2026.
• REMARKS: Power of Attorney is on file.